<- Go Home
Paxman AB (publ)
Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide. It serves various cancer centers and hospitals. The company has collaborated with the University of Huddersfield and the University of Leeds to utilize state-of-the-art technological advances to develop a wearable medical cooling device, and the National University Hospital of Singapore for the development of a cooling and compression system. Paxman AB (publ) was founded in 1996 and is headquartered in Karlshamn, Sweden.
Market Cap
SEK 1.7B
Volume
33.8K
Cash and Equivalents
SEK 152.7M
EBITDA
SEK 48.4M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
SEK 179.5M
Profit Margin
65.96%
52 Week High
SEK 85.80
52 Week Low
SEK 44.00
Dividend
N/A
Price / Book Value
6.26
Price / Earnings
73.55
Price / Tangible Book Value
7.26
Enterprise Value
SEK 1.6B
Enterprise Value / EBITDA
32.75
Operating Income
SEK 32.3M
Return on Equity
10.48%
Return on Assets
7.99
Cash and Short Term Investments
SEK 152.7M
Debt
SEK 9.5M
Equity
SEK 276.0M
Revenue
SEK 272.1M
Unlevered FCF
SEK 10.5M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium